Turbett Sarah E, Lazarus Jacob E, Nardini Mia A, Braidt Joseph E, Lane Stefanie A, Searle Eileen F, Biddinger Paul D, Shenoy Erica S
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Infect Control Hosp Epidemiol. 2024 Oct 11;45(9):1-7. doi: 10.1017/ice.2024.143.
Viral hemorrhagic fevers (VHFs), such as Ebola virus disease, Marburg virus disease, and Lassa fever, are associated with significant morbidity and mortality and the potential for person-to-person transmission. While most individuals in whom VHF is suspected will ultimately be diagnosed with a non-VHF illness, such patients may present to any United States healthcare facility (HCF) for initial evaluation; therefore, all HCFs must be prepared to evaluate and initiate care for suspect VHF patients, especially if they are acutely ill. Included within this evaluation is the ability to perform basic routine laboratory testing before VHF-specific diagnostic test results are available, as well as rapid malaria testing to assess for a common, dangerous "VHF mimic."
To improve laboratory preparedness and readiness in the initial care of suspect VHF patients who may present to acute care hospitals.
Plan-Do-Study-Act quality improvement model.
Frontline healthcare facilities and their clinical laboratories.
We describe the development of a laboratory testing toolkit for a suspect VHF patient that can assist frontline HCFs in providing basic laboratory testing required for the care of these patients.
The toolkit provides guidance on infection prevention and control, waste management, occupational health, laboratory test collection, processing, and resulting, in the context of suspect VHF patient evaluation.
The toolkit is designed to be readily adapted by any frontline HCF in the US. With the guidance provided, facilities will be able to support safer initial evaluation of VHF suspects and ensure high-quality patient care.
病毒性出血热(如埃博拉病毒病、马尔堡病毒病和拉沙热)与严重的发病率和死亡率以及人际传播的可能性相关。虽然大多数疑似感染病毒性出血热的个体最终会被诊断为非病毒性出血热疾病,但这类患者可能会前往美国任何一家医疗机构(HCF)进行初步评估;因此,所有医疗机构都必须做好准备,对疑似病毒性出血热患者进行评估并开始治疗,尤其是那些病情危急的患者。该评估包括在获得病毒性出血热特异性诊断检测结果之前进行基本常规实验室检测的能力,以及进行快速疟疾检测以评估一种常见的、危险的“类病毒性出血热疾病”。
提高可能前往急症医院就诊的疑似病毒性出血热患者初始治疗中的实验室准备水平和应对能力。
计划-实施-研究-改进质量改进模型。
一线医疗机构及其临床实验室。
我们描述了一种针对疑似病毒性出血热患者的实验室检测工具包的开发情况,该工具包可协助一线医疗机构提供这类患者治疗所需的基本实验室检测。
该工具包在疑似病毒性出血热患者评估的背景下,提供了关于感染预防与控制、废物管理、职业健康、实验室检测采集、处理及结果分析的指导。
该工具包旨在便于美国任何一线医疗机构采用。在提供的指导下,各机构将能够支持对疑似病毒性出血热患者进行更安全的初始评估,并确保高质量的患者护理。